In 2014, the Society for Integrative Oncology first published clinical guidelines for the care of breast cancer patients. Not surprisingly, SIO advocated “integrating” dubious therapies with oncology. Last week, the most influential oncology society, the American Society of Clinical Oncology (ASCO), endorsed a 2017 update to the SIO guidelines, thus endorsing the “integration” of quackery with oncology and paving the way for insurance coverage. The advance of quackademic medicine in oncology continues apace.
Tag: ASCO
Evidence-based medicine guidelines versus patient wishes
There’s a misconception that I frequently hear about evidence-based medicine (EBM), which can equally apply to science-based medicine (SBM). Actually, there are several, but they are related. These misconceptions include the idea that EBM/SBM guidelines are a straightjacket, that they are “cookbook medicine,” and that EBM/SBM should be the be-all and end-all of how to practice clinical medicine. New readers might not be familiar with the difference between EBM and SBM, and here is not the place to explain the difference in detail because this post isn’t primarily about that difference. The CliffsNote version is that EBM fetishizes the randomized …
Quackademic medicine infiltrates a major cancer conference
As if yesterday’s post weren’t depressing enough, last weekend I attended the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago, which is part of the reason I didn’t produce much in the way of posts about a week ago. Last Sunday, while aimlessly wandering from session to session and checking Twitter and e-mail between sessions, I noticed that a lot of people, including the official ASCO Twitter feed @ASCO, were Tweeting and re-Tweeting a link to this official story from ASCO, “Integrative Oncology Can Add Benefit to Traditional Cancer Treatments.” It was a description of …